Quijano, Asher Edrian .
HRN: 21-15-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2022
MUPIROCIN 2%, 15G (TUBE)
05/15/2022
05/21/2022
TOPICAL
2% Ointment
2x A Day For 7 Days
IV Site Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes